GLUCOPHYTON Rationale of the project and description of ingredients.

Slides:



Advertisements
Similar presentations
Insulin Therapy in Type 2 Diabetes: Current and Future Directions
Advertisements

The Aging Brain The brain changes with age The frontal cortex & hippocampus are critical to learning, memory, planning and other cognitive activities,
Green Tea Beth Kalicki Heli Roy, PhD, RD Division of Education Pennington Biomedical Research Center.
The concept of Diabetes & CV risk: A lifetime risk challenge Vascular function as an early sign of trouble: How can the inhibition of cholesterol absorption.
Clinical Trials Importance in future therapies. What are the Requirements to Produce New Drugs? Drug must work significantly better than a control treatment.
Farxiga™ - Dapagliflozin
Women’s Health Study: Vitamin E in Primary Prevention Presented at American College of Cardiology Scientific Sessions 2005 Presented by Dr. Julie E. Buring.
What is Diabetes? Diabetes is a chronic disease that occurs either when the pancreas does not produce enough insulin or when the body cannot effectively.
Effects of Diet and Exercise on Memory Insulin Overview Alzheimer's as Type 3 Diabetes Beta Amyloid in Alzheimer's Exercise Cholesterol Vitamin B12.
Supplementation of vitamin C reduces blood glucose and improves glycosylated hemoglobin in T2DM Mellitus: a randomized, double-blind study. Dakhale GN,
Introduction Hypothesis Conclusions and Limitations Specific Aims Effects of Apple Cider Vinegar on Postprandial Glucose Levels in Adults with Type 2 Diabetes.
Robert Farley Biomedical Engineering.  Engineered blood vessels made from autologous cells  Autologous cells – cells used to build the vessels are extracted.
Alzheimer's disease Beta amyloid protein and the potential for anti-oxidants drugs.
Drug Testing GRADE C Describe the main steps in testing a new drug.
Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes.
Healthy Trac™ Market For Digestive Health #2 Retail Product Category ($2 Billion). 60 Million Suffer Digestive Health Problems Each Year. #1 Reason For.
The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. Susan A. Farr, et al.
The lowdown on Ginkgo Biloba Gold, PE at al.. Use of Ginkgo Biloba can be traced back centuries in Chinese traditional medicine Most widely-used herbal.
Diabetes: The Modern Epidemic Roy Buchinsky, MD Director of Wellness.
Diet and Alzheimer’s disease Andy Smith School of Psychology Cardiff University.
Journal Club 2009 年 1 月 29 日(木) 8 : 20 ~ 8 : 50 B 棟 8 階カンファレンスルーム 薬剤部 TTSP 石井 英俊.
Precocious “AGE’ing” in Diabetes Precocious “AGE’ing” Effect of Type 1 Diabetes Background T1DM increases formation of advanced glycation end products.
Pediatric Endocrinology Use of Biologic and Chemotherapeutic Agents Pediatric Endocrinology Use of Biologic and Chemotherapeutic Agents.
Drug Development —— Metformin. Diabetes type1 vs type2.
Anatomy and physiology of t2d Lesson Five Today we will… Make a human body poster that shows how t2d affects organs and body systems Look at treatment.
Part 8. Rationale for SGLT2 Inhibitors Inhibit glucose reabsorption in the renal proximal tubule Resultant glucosuria leads to a decline in plasma glucose.
Follow Up Questions Diabetes is caused by an increase in blood glucose. People with diabetes II also have a very high risk for developing Alzheimer’s disease.
Control of Attention in schizophrenia 1.Advance understanding of schizophrenia. Move from description of deficits to explanation of specific mechanisms.
Compound from Red Wine is Helpful to Slow the Development of Alzheimer Alzheimer is one of the most common diseases among the elderly as aging playing.
Enzogenol ® improves brain function – A clinical trial Brain Sciences Institute, Swinburne University, Melbourne Enzogenol significantly improved cognitive.
 GLP-1 agonists have shown to help patients lose weight  Mechanism of GLP-1 agonists  Cardioprotective effects of GLP-1 agonists  GLP-1 agonists and.
TRA Complex provides: Banaba Leaf (32 mg) Chromium (200 mcg) Vanadium (30 mcg) to help promote normal glucose/insulin responses and reduce carbohydrate.
Prevention Of Diabetes. Type 2 Diabetes: Hyperglycemia Insulin Resistance Relative Impairment of Insulin Secretion Pathogenesis: Poorly Understood Genetic.
Part 1 of 4. Program Editors Ralph Anthony DeFronzo, MD Professor of Medicine and Chief of the Diabetes Division University of Texas Health Science Center.
European Patients’ Academy on Therapeutic Innovation Special Populations.
Oral Diabetes Medications Carol Cordy, MD. Goals Understand how type 2 diabetes affects many organs and how this changes over the course of the illness.
Session 5: Biological Factors & Cognition. 1. Human beings are information processors and mental processes guide behaviour 2. The mind can be studied.
GLP-1 Agonists and DPP-4 Inhibitors How do they work? Part 4.
นพ. เฉลิมศักดิ์ สุวิชัย โรงพยาบาล พะเยา. Management of Type 2 Diabetes Mellitus: A New Paradigm Approach Dr. Chalermsak Suwichai Phayao Hospital.
The MICRO-HOPE. Microalbuminuria, Cardiovascular and Renal Outcomes in the Heart Outcomes Prevention Evaluation Reference Heart Outcomes Prevention Evaluation.
Primary Care Prescribing for Type 2 Diabetes Dr. David Jenkins Worcestershire Royal Hospital.
Circulation. 2014;129: Association Between Plasma Triglycerides and High-Density Lipoprotein Cholesterol and Microvascular Kidney Disease and Retinopathy.
Date of download: 6/24/2016 From: Sodium–Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes: A Systematic Review and Meta-analysis Ann Intern Med.
Welcome to Unit 7’s seminar: Children and Attention Disorders Do we have any questions about the Unit 5 project? …about Unit 6?
The process of drug development. Drug development 0,8 – 1 mld. USD.
Date of download: 9/17/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Insulin Therapy for Type 2 Diabetes Mellitus JAMA.
Lecture 6 TOXICITY Toxicity from excessive dietary intake of major minerals rarely occurs in healthy individuals. Kidneys that are functioning normally.
DIABETES MELLITUS. Diabetes mellitus (DM) is a metabolic disorder resulting from a defect in insulin secretion, insulin action, or both. DM is associated.
Figure 2. Effect of Siberian and Panax ginseng respectively on postprandial glucose level before and after three months of intake in patients with type.
Drug Discovery &Development
Chapter 7 Metabolic syndrome
Faculty of Psychology and Neuroscience
HOPE: Heart Outcomes Prevention Evaluation study
Neal B, et al. Diabetes Care 2015;38:403–411
Dapagliflozin Improves Hyperglycemia and Beta-Cell Function Without Increasing Hypoglycemic Episodes in Patients With Type 2 Diabetes Mellitus Afshin Salsali.
Empagliflozin (Jardiance®)
A Health Crisis In 2015, more than 30.2 million US adults over 18 (9.4%) had diabetes About 84.1 million US adults have prediabetes That is about a third.
NUTRITION AND FITNESS LIFESYTLE CHANGE PROGRAM
SGLT2 Inhibitors and Their Clinical Impact:
Sodium-glucose co-transporter 2 (SGLT2) inhibitors work by blocking the reabsorption of filtered glucose in the kidneys. This leads to glucosuria and improved.
Figure 2 Glucose handling by the kidney
Cognitive enhancement by drugs in health and disease
Dual SGLT1/SGLT2 Inhibition in T1D
James F. List, Jean M. Whaley  Kidney International 
Cosmetic Benefits of Astaxanthin on Human Subjects
Collin Belk, Kelly Ferris, Kirsten Carstarphen, Jace Engstler, Dr
Higher Human Biology Unit 3 – Neurobiology and Immunology
GLP-1 Agonists and DPP-4 Inhibitors How do they work?
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists and Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: How Do They Exert Their Metabolic Actions? Part 7.
Presentation transcript:

GLUCOPHYTON Rationale of the project and description of ingredients

Design of a phytonutraceutical formulation to: Control post-prandial plasma glucose levels by A) reducing glycemic index of food B) increasing glucose excretion Reduce the synthesis of Advanced Glycation End products (AGEs) Reduce the synthesis of Advanced Lipoperoxydation End Products (ALEs) As a consequence of these goals, to prevent and/or to decrease complications of diabetes OBJECTIVES

Innovative blend combining inhibitors of Glycosidase, inhibitors of SGLT-2 (sodium-glucose cotransporter 2) and inhibitors of the synthesis of Advanced Glycation End products and the synthesis of Advanced Lipoperoxydation End products INGREDIENTS Morus alba L-carnosinePyridoxal-5-phosphate

APPLE TREE BARK Pharmacological Evidences Phlorizin is a well-known SGLT-2 inhibitor, causing glucosuria both in dogs and humans

1-deoxynojirimycin (DNJ) and some of its derivatives are well known as an alpha- glucosidase inhibitors PHARMACOLOGICAL EVIDENCES CLINICAL EVIDENCES Randomized open, cross-over study in 10 healthy women given M.alba extract and selected carbohydrates Suppresion of post-prandial blood glucose and insulin levels

PHARMACOLOGICAL EVIDENCES Carnosine inhibits in vitro low-density Lipoprotein oxydation Carnosine delays senescence of human cultured diploid fibroblasts CLINICAL EVIDENCES Randomized double blind placebo controlled study of effects on cognition and mood in the healthy elderly volunteers Working memory (Bond-Lader visual analogue Scales) increased in 28 subjects after two months of treatment.

PHARMACOLOGICAL EVIDENCES Decrease of beta-amyloid-induced cognitive dysfunction and neurotoxicity Protective effect on Abeta(1-42)-induced neuronal cell death and memory impair- ment of mice. CLINICAL EVIDENCES Double blind, placebo controlled study of effects of 100 mg of L-theanine + 50 mg of caffeine on EEG and scores of attention tests in 16 healthy volunteers Double blind, placebo controlled study of effects of 100 mg of L-theanine + 50 mg of caffeine on cognition and mood in healthy volunteers.

INDICATIONS HEALTHY Increase of attention and short term memory Increase of cognitive function Increase of alertness Decrease of neuronal degeneration due to senescence, toxins and oxidative damage PATIENTS Decrease of neuronal degeneration in Alzheimer patients Protective effect on environmental toxins-induced neuronal cell death Mood improvement in children with attention deficit with hyperactivity

SUMMARY New formulation not described else where Activity of ingredients demonstrated in “vitro” and “in vivo pharmacological studies Well known and safe ingredients, most of them with a specif monograph in US Pharmacopea and/or other pharmacopeas Ingredients easyly available All the ingredients have shown beneficial effects on cognitive function, memory and mental altertness in Evidence Based Clinical Trials Formulation useful in children, adults and elderly Formulation likely useful because it considers most of the known mechanisms involved in cognitiva function